Biohaven Pharmaceutical Soars 72% on Premium $11.6B Deal by Pfizer
(Pfizer) Shares of Biohaven Pharmaceutical rose more than 72% in premarket on Tuesday after news Pfizer will acquire it for $11.6 billion in cash. The deal values Biohaven at $148.50,…